WHG
SUPN icon

Westwood Holdings Group’s Supernus Pharmaceuticals SUPN Stock Holding History

Westwood Holdings Group’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7,213
Closed -$222K – 473
2021
Q2 		$222K Buy
+7,213
New +$221K ﹤0.01% 427

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Westwood Holdings Group's SUPN Position: Q3 2021 in Review

Westwood Holdings Group sold out of Supernus Pharmaceuticals (SUPN) in Q3 2021, closing a stake of 7,213 shares — an estimated $222K sold.

Westwood Holdings Group first reported a position in SUPN in Q2 2021 and held it in 1 quarter. The position peaked at $222K in Q2 2021. 223 funds tracked by Wall St. Rank hold SUPN as of Q3 2021.

  • Westwood Holdings Group reported no remaining Supernus Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Westwood Holdings Group sold 7,213 Supernus Pharmaceuticals shares in Q3 2021, an estimated $222K.
  • Westwood Holdings Group first reported a position in Supernus Pharmaceuticals in Q2 2021 and held it in 1 quarter.
  • Westwood Holdings Group's Supernus Pharmaceuticals position peaked at $222K in Q2 2021.
  • 223 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2021.

Based on Westwood Holdings Group's 13F filing for Q3 2021, filed 12 Nov 2021.